Emerg Infect Dis by Wang, Xinyu et al.
  6. Liu B, Havers FP, Zhou L, Zhong H, Wang X, Mao S, et al.  
Clusters of human infections with avian influenza A(H7N9) virus 
in China, March 2013 to June 2015. J Infect Dis. 2017;216 
(Suppl_ 4):S548–S554. http://dx.doi.org/10.1093/infdis/jix098
  7. Fang CF, Ma MJ, Zhan BD, Lai SM, Hu Y, Yang XX, et al.  
Nosocomial transmission of avian influenza A (H7N9) virus in 
China: epidemiological investigation. BMJ. 2015;351:h5765.  
http://dx.doi.org/10.1136/bmj.h5765
  8. Chen H, Liu S, Liu J, Chai C, Mao H, Yu Z, et al. Nosocomial  
co-transmission of avian influenza A(H7N9) and A(H1N1)pdm09 
viruses between 2 patients with hematologic disorders. Emerg Infect 
Dis. 2016;22:598–607.  http://dx.doi.org/10.3201/eid2204.151561
  9. Uyeki TM, Katz JM, Jernigan DB. Novel influenza A viruses  
and pandemic threats. Lancet. 2017;389:2172–4.  
http://dx.doi.org/10.1016/S0140-6736(17)31274-6
Address for correspondence: Qun Li, Public Health Emergency Center, 
Chinese Center for Disease Control and Prevention, Beijing, 102206, 
China; email: liqun@chinacdc.cn
Human African  
Trypanosomiasis in Emigrant 
Returning to China from  
Gabon, 2017
Xinyu Wang,1 Qiaoling Ruan,1 Bin Xu,1  
Jianfei Gu, Yiyi Qian, Muxin Chen, Qin Liu,  
Qing Lu, Wenhong Zhang
Author affiliations: Fudan University, Shanghai, China (X. Wang, 
Q. Ruan, B. Xu, J. Gu, Y. Qian, Q. Lu, W. Zhang); Chinese Center 
for Disease Control and Prevention, WHO Collaborating Center 
for Tropical Diseases, Shanghai (M. Chen, Q. Liu)
DOI: https://doi.org/10.3201/eid2402.171583
Human African trypanosomiasis is endemic to parts of sub-
Saharan Africa and should be considered in the differential di-
agnosis of patients who have visited or lived in Africa. We re-
port a 2017 case of stage 2 Trypanosoma brucei gambiense 
disease in an emigrant who returned to China from Gabon.
Human African trypanosomiasis (HAT), or sleeping sick-ness, is a tsetse fly–borne parasitic disease that is endem-
ic to parts of sub-Saharan Africa. In central and west Africa, 
Trypanosoma brucei gambiense causes the slow-progressing 
form of the disease, and T. brucei rhodesiense causes the fast-
progressing form in east and southern Africa (1). We report 
a confirmed case of HAT, after a probable tsetse fly bite, in a 
man who returned to China from Gabon in central Africa.
A previously healthy 60-year-old man from China 
lived in Gabon for 8 years. He served as a seaman and 
traveled between Libreville and Kango to transport river 
sand. In July 2016, when he was working on a rural farm 
in Libreville, he had a painful, unidentified insect bite on 
his right lower limb. The bite wound developed into an in-
durated, erythematous, and painful skin lesion. He received 
antiviral and antityphoid therapy in Gabon. Although the 
skin lesion healed, he had intermittent fever (up to 40°C), 
headache, and fatigue. 
He returned to Jiangshu, China, for further treatment in 
June 2017. Magnetic resonance imaging (MRI) of the brain 
revealed temporal foci suggestive of white matter demyelin-
ation. Brain magnetic resonance angiography and electro-
encephalography revealed normal findings. He had daytime 
somnolence 2 weeks before admission to Huashan Hospital, 
associated with Fudan University in Shanghai, on August 30. 
The patient was lethargic during admission and had a tem-
perature of 38.5°C and palpable cervical and inguinal lymph 
nodes. Hyperpigmentation of the right lower limb was vis-
ible. Meningeal irritation and the Babinski sign were absent.
The preliminary diagnosis was suspected HAT. We per-
formed bone marrow puncture, which revealed a few trypo-
mastigotes (Trypanosoma spp.; Figure 1, panel A). We also 
found trypanosomes in a peripheral blood smear. We sent a 
serum sample to the Chinese Center for Disease Control and 
Prevention (China CDC), which showed a positive result for 
the T. brucei gambiense antibody test. A cerebrospinal fluid 
(CSF) sample revealed an open pressure of 15 cm H2O, a 
leukocyte count of 9 cells/μL, a protein level of 1,412 mg/
dL, and a glucose level of 1.6 mmol/L. Direct examination 
revealed no trypanosomes in the CSF, although next-gener-
ation sequencing identified T. brucei gambiense in the CSF 
and bone marrow (stage 2 disease). Brain MRI revealed hy-
perintense signal changes in the left basal ganglia, and posi-
tron emission tomography–computed tomography suggested 
reduced glucose metabolism (Figure 1, panels B, C). The 
World Health Organization (WHO) and China CDC helped 
obtain nifurtimox and eflornithine, which we administered 
to the patient within 48 h after the diagnosis. The patient was 
discharged after 10 days of treatment.
Several HAT cases had previously been imported 
into China. One case-patient was a 45-year-old man who 
worked in forests and river valleys in Gabon and was di-
agnosed with T. brucei gambiense disease by blood smear 
in 2014, two months after returning to China (2). The sec-
ond case involved a woman, 41 years of age, who traveled 
to Tanzania and Kenya, and was diagnosed with T. brucei 
rhodesiense by blood smear in 2017, one week after re-
turning to China. Both cases were confirmed by molecular 
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diagnosis. Additional cases may have been imported to 
China, but we could not find any reports after a review of 
literature and available national records. 
The latest data from WHO indicate that new HAT 
cases have declined during the past 15 years, reaching 
a low of 2,184 cases in 2016 (3). Nevertheless, HAT 
cases exported from Africa have been reported in all 
continents. In non–HAT-endemic areas, 94 cases of HAT 
were reported during 2000–2010, including 26 cases of 
T. brucei gambiense disease (4). T. brucei rhodesiense 
disease typically involves tourists who have visited na-
tional parks and game reserves in eastern and southern 
Africa, whereas T. brucei gambiense disease is rarer and 
typically involves migrants and long-term emigrants (1). 
Persons in Gabon are at risk for T. brucei gambiense 
infection; 403 cases were reported during 2010–2014 
(4). Nine exported HAT cases from Gabon have been re-
ported, including 5 from Libreville; all these cases were 
T. brucei gambiense disease, and 6 were in immigrants 
from various countries (2,5–7).
Although HAT is uncommon in nonendemic set-
tings, it should be included in the differential diagnosis 
of travelers who return from sub-Saharan Africa with 
fever. T. brucei rhodesiense disease causes acute illness 
and usually manifests as severe parasitemia; thus, the di-
agnosis is easier and quicker. In contrast, T. brucei gam-
biense disease usually has a chronic progressive course, 
with an estimated untreated infection duration of 2 years 
(8). Blood film review is essential for the early detection 
of HAT. Moreover, T. brucei gambiense infection can be 
reliably diagnosed by testing for specific antibodies, al-
though this test is not available in most areas of China. 
As in this case, next-generation sequencing technolo-
gies are useful for diagnosing unknown tropical febrile 
illnesses (9). Because rapid diagnosis and treatment 
of HAT are essential, countries with large populations 
of travelers to HAT-endemic regions should maintain 
diagnostic tools and appropriate medication to facilitate 
rapid clinical management.
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Figure. Bone marrow test results 
and brain imaging of a 60-year-
old man who returned to China 
from Gabon with suspected 
human African trypanosomiasis. 
A) Trypanosoma spp. (later 
determined to be T. brucei 
gambiense) in a Giemsa-stained 
thin bone marrow film. Original 
magnification ×1,000. B) A 
T2-weighted fluid-attenuated 
inversion recovery image with 
hyperintense signal changes in 
the left basal ganglia. C) Brain 
positron emission tomography–
computed tomography suggested 
reduced glucose metabolism in 
the left basal ganglia.
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Dengue can cause neurologic complications in addition to 
the more common manifestations of plasma leakage and 
coagulopathy. Posterior reversible encephalopathy syn-
drome has rarely been described in dengue, although the 
pathophysiology of endothelial dysfunction likely underlies 
both. We describe a case of dengue-associated posterior 
reversible encephalopathy syndrome and discuss diagnosis 
and management.
On December 20, 2015, a 55-year-old woman in Viet-nam sought medical care at her local hospital near Ho 
Chi Minh City with 1 day of fever, muscle aches, and an-
orexia. She had no remarkable medical history; she did not 
take any medications and had not received any recent vac-
cinations. Initial hematology and biochemistry tests were 
normal, but a rapid test for dengue nonstructural protein 1 
antigen was positive. She remained hemodynamically sta-
ble and did not experience any bleeding or have evidence 
of plasma leakage. On December 24, she had a generalized 
convulsion and was transferred to the intensive care unit at 
the Hospital for Tropical Diseases.
At admission, her Glasgow Coma Scale score was 
10/15 (eyes 3, motor 4, voice 3); she was confused, 
and speech was slurred. Her temperature was 37.5°C, 
heart rate was 100 beats/min, blood pressure was 140/90 
mmHg, and respiratory rate was 18 breaths/min. Cardio-
respiratory and abdominal examinations were normal. 
Neurologic examination demonstrated increased tone 
in upper and lower limbs and bilateral upgoing plan-
tar reflexes; assessment of power was difficult because 
of generalized rigidity. Examination of her eye move-
ments demonstrated vertical gaze palsy, but other cranial 
nerves were intact.
Blood tests showed hemoglobin level of 14 g/dL, he-
matocrit level of 42.2%, a white cell count of 11 × 109 
cells/L, and a platelet count of 100 × 109/L. A test for 
dengue nonstructural protein 1 antigen remained positive, 
but PCR was negative. Urea and electrolyte levels were 
normal, but liver transaminases showed elevated aspartate 
aminotransferase of 386 U/L and alanine aminotransfer-
ase of 242 U/L. Chest radiograph was unremarkable, but 
a brain computed tomography scan demonstrated bilat-
eral cerebral and cerebellar white matter hypodensities. 
Lumbar puncture demonstrated an opening pressure of 12 
cm H2O, a cerebrospinal fluid (CSF) cell count of 7 cells/
µL, a red cell count of 4 cells/µL, protein level of 4.4 g/
dL, glucose level of 4.76 mmol/L (10.4 mmol/L in blood), 
and lactate level of 3.25 mmol/L. Dengue virus IgM was 
detected in CSF; Japanese encephalitis virus IgM was 
negative. CSF dengue and herpes simplex virus PCR were 
negative. Microbiologic cultures performed on blood and 
CSF were sterile.
Magnetic resonance imaging (MRI) of the brain, per-
formed the following day, demonstrated bilateral symmet-
ric high signal on T2-weighted and fluid attenuation inver-
sion recovery images, involving periventricular and deep 
cerebral white matter (Figure, panel A). The differential 
diagnoses included encephalitis or acute demyelinating 
encephalomyelitis (ADEM), and a course of intravenous 
methylprednisolone was started (1 g/d). After 5 days, this 
regimen was converted to oral prednisolone (60 mg/d), ta-
pering over 5 days. Phenobarbital was administered for 1 
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